Provided by Tiger Trade Technology Pte. Ltd.

Rani Therapeutics Holdings

1.59
+0.02001.27%
Post-market: 1.610.0173+1.09%19:46 EST
Volume:2.33M
Turnover:3.75M
Market Cap:193.20M
PE:-2.10
High:1.67
Open:1.58
Low:1.55
Close:1.57
52wk High:3.87
52wk Low:0.3870
Shares:121.51M
Float Shares:66.89M
Volume Ratio:0.80
T/O Rate:3.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7588
EPS(LYR):-1.0541
ROE:-1187.52%
ROA:-95.52%
PB:-24.58
PE(LYR):-1.51

Loading ...

Rani Therapeutics Amends Certificate of Incorporation

Reuters
·
Yesterday

Rani Therapeutics Holdings Amends Certificate of Incorporation

Reuters
·
Nov 26

H.C. Wainwright Sticks to Its Buy Rating for Rani Therapeutics Holdings (RANI)

TIPRANKS
·
Nov 07

Rani Therapeutics Reports Financial Challenges Amid Innovation

TIPRANKS
·
Nov 07

Rani Therapeutics Holdings posts net loss of $31.9 million for Q3 2025

Reuters
·
Nov 07

Rani Therapeutics Appoints Abraham Bassan and Vasudev Bailey to Board

Reuters
·
Nov 07

Rani Therapeutics Holdings Inc - Announces $1.085 Bln Collaboration With Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics

THOMSON REUTERS
·
Nov 07

Rani Therapeutics Holdings Inc - Expects Cash Runway to Extend Into 2028

THOMSON REUTERS
·
Nov 07

Press Release: Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

Dow Jones
·
Nov 07

Stocks to Watch: Getty Images, Rani Therapeutics, Middlesex Water

Dow Jones
·
Nov 01

Rani Therapeutics Holdings Inc. Files Initial Statement of Beneficial Ownership for Director Vasudev Jaiprakash Bailey

Reuters
·
Oct 31

Director Makes Bold Move with Massive Stock Purchase in Rani Therapeutics!

TIPRANKS
·
Oct 28

Rani Therapeutics Holdings Inc. Files Initial Statement of Beneficial Ownership for Director Abraham Bassan

Reuters
·
Oct 28

Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114

TIPRANKS
·
Oct 28

Rani Therapeutics Completes Private Placement of Shares

TIPRANKS
·
Oct 27

Rani Therapeutics (RANI): Evaluating Valuation Following Chugai Partnership and Major Private Placement

Simply Wall St.
·
Oct 27

Why Rani Therapeutics Holdings (RANI) Is Up 11.0% After Major Chugai Deal, Board Appointments, and $60M Raise

Simply Wall St.
·
Oct 26

Epam, Westinghouse, Kala, Rani, Verisign: Major Stock Moves!

TIPRANKS
·
Oct 25

Press Release: Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

Dow Jones
·
Oct 24

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Oct 24